Founded in 2005, the Brain Institute combines interdisciplinary and translational approaches to improve treatments for neurological and psychiatric disorders, and brain and spinal cord injuries.
One in 26 people will have a seizure in their lifetime. Nearly half will go through the unpredictable and sometimes life-threatening experience at least once more, and many will receive a diagnosis of epilepsy. Seizures are caused by groups of neurons in the brain firing uncontrollably. There are many different kinds of seizures that differ based on which neurons are affected, how they are triggered, and how they spread. Nathan Anthony Smith, Ph.D., a postdoctoral scientist for both the Neuronal Dynamics, and Glial-Neuronal Interactions in Epilepsy laboratories at the Brain Institute at the University of Utah, is investigating how astrocytes, long considered inert support cells for neurons, contribute to specific types of seizures. READ MORE
Mauna Kea Technologies launched a collaboration with the Laboratory of Robert Hitchcock, Ph.D., Department of Bioengineering, to develop a novel technology to monitor and diagnose lung disease. CellVizio is an ultra-thin, fiber optic confocal endomicroscope that can extend to the distal lung, reaching areas where the traditional bronchoscope cannot. Hitchcock’s group and the University of Edinburgh are integrating this imaging device into an advanced pulmonary access catheter, a breakthrough that will allow physicians to visualize cancer margins and microstructures within living tissue in real-time, leading to faster, more accurate diagnoses. READ MORE